Masakuni Kori

2-{3-[4-(Alkylsulfinyl)phenyl]-1-benzofuran-5-yl}-5-methyl-1,3,4-oxadiazole Derivatives as Novel Inhibitors of Glycogen Synthase Kinase-3β with Good Brain Permeability

Morihisa Saitoh, Jun Kunitomo, Eiji Kimura et al. · Journal of Medicinal Chemistry · 2009 · 122 citations · Full text

-5-Methyl-1,3,4-oxadiazole Derivatives, Good Brain Permeability, Pharmacotherapy +19

A novel glycogen synthase kinase‐3 inhibitor 2‐methyl‐5‐(3‐{4‐[(<i>S </i>)‐methylsulfinyl]phenyl}‐1‐benzofuran‐5‐yl)‐1,3,4‐oxadiazole decreases tau phosphorylation and ameliorates cognitive deficits in a transgenic model of Alzheimer’s disease

Tomohiro Onishi, Hiroki Iwashita, Yumiko Uno et al. · Journal of Neurochemistry · 2011 · 89 citations · Full text

Amyloid β, Brain Penetration, Neurochemical Biomarkers +28

Synthesis of Novel 4,1-Benzoxazepine Derivatives as Squalene Synthase Inhibitors and Their Inhibition of Cholesterol Synthesis

Takashi Miki, Masakuni Kori, Hiroshi Mabuchi et al. · Journal of Medicinal Chemistry · 2002 · 80 citations · Full text

Total Synthesis of Rapamycin

Steven V. Ley, Miles N. Tackett, Matthew L. Maddess et al. · Chemistry - A European Journal · 2009 · 62 citations

Syntheses of fused heterocyclic compounds and their inhibitory activities for squalene synthase

Takashi Miki, Masakuni Kori, Akira Fujishima et al. · Bioorganic & Medicinal Chemistry · 2002 · 57 citations

Engineering, Heterocyclic, Biochemistry +10